NIH-funded research Career grant

Investigating how iron overload in immune cells affects COPD

Official title: Alveolar Macrophage Iron Overload in COPD Pathogenesis

Funded at Weill Medical Coll of Cornell Univ · NIH-10890163 · Data updated 2026-11-12

This study is looking at how certain immune cells in the lungs, called alveolar macrophages, are affected by cigarette smoke and how this might lead to worsening COPD, with the hope of finding new ways to help improve treatment for people with this condition.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 1, 2023
Project endJuly 30, 2028
Funding year2024
Award (this year)$169,020
NIH project number5K08HL165081-02
Project IDNIH-10890163 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease, particularly those with a history of smoking.

Less likely to help

Patients with COPD who do not have a history of smoking or those with other unrelated respiratory conditions may not benefit from this research.

What this research studies

This research focuses on understanding the role of alveolar macrophages, a type of immune cell in the lungs, in the development of chronic obstructive pulmonary disease (COPD). It aims to uncover how cigarette smoke leads to dysfunction in these cells and contributes to lung damage and disease progression. By analyzing samples from a large cohort of COPD patients and using advanced techniques like single-cell RNA sequencing, the study seeks to identify specific cellular changes related to iron accumulation. This could provide insights into new therapeutic targets for improving COPD outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that target iron overload in immune cells, potentially improving the health and quality of life for COPD patients.

How similar studies have gone: Previous research has shown promising results in understanding the role of immune cells in COPD, but this specific approach focusing on iron overload is relatively novel.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Zhang, William Zhengyang — Weill Medical Coll of Cornell Univ
  • Study coordinator: Zhang, William Zhengyang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.